Filters

Latest News

2022-07-19 12:00:30

Pharma proposes to work with G7 and G20 on a joint solution for better access to vaccines and treatments around the world for future pandemics

For future pandemics, we will build on the achievements which led to developing and scaling up multiple safe and effective ...

Read More

2022-06-21 09:39:33

Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany and global pandemic response involving the G7

Berlin, 21 June, 2022 – Today, global leaders from the pharmaceutical industry met with German ...

Read More

2022-06-17 07:12:58

Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the World Trade Organization Ministerial Conference

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken ...

Read More

2022-05-23 08:17:57

Improving access to and use of essential life-saving cancer medicines in LLMICs

This news release was originally published by UICC on 20 May 2022. IFPMA and many ...

Read More

2022-05-22 23:00:57

Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response

Swift pathogen surveillance and sharing, an enabling innovation ecosystem, and regulatory agility are among the ...

Read More

2022-04-26 17:00:48

Celebrating World IP Day with a focus on youth and innovation

Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of ...

Read More

2022-04-13 12:45:21

COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks

To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...

Read More

Latest Statement

2022-09-28 17:00:54

IFPMA statement at the 74th session of the WHO Regional Committee for the Americas on the COVID-19 pandemic in the region of the Americas

28 September 2022, Washington, DC, USA — IFPMA welcomes the opportunity to share our from Covid-19 Lessons Learned, which highlights ...

Read More

2022-09-28 15:00:25

IFPMA Statement at the WHO Second Public Hearings to support the intergovernmental negotiating body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

2022-09-13 11:00:07

IFPMA and GSCF statement at the 72nd session of the WHO Regional Committee for Europe on Strengthening health emergency preparedness, response, and resilience: learning the lessons and building back better

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

2022-09-13 10:00:34

R&D based biopharmaceutical industry statement in support of the Seventh Global Fund Replenishment

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

2022-09-07 11:32:38

IFPMA statement at the 75th session of the WHO Regional Committee for South-East Asia on Monitoring progress and acceleration plan for NCDs

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

2022-08-24 15:15:20

IFPMA statement at the 72nd session of the WHO Regional Committee for Africa: Regional strategy for health security and emergencies 2022-2030

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

2022-07-19 14:09:04

IFPMA written statement for the second meeting of the intergovernmental negotiating body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention preparedness and response

To date, over 13 billion doses of COVID-19 vaccines have ...

Read More

mailto:a.jones@ifpma.org

Abigail Jones - Director, Communications

Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.

mailto:m.depol@ifpma.org
Twitter @MorganePol

Morgane De Pol - Deputy Director, Communications

Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

News Release

meeting-discusses-covid-19-vaccine-manufacturing-bottlenecks-that-must-be-urgently-tackled-for-c19-vaccine-output-to-reach-its-full-potential

Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential

9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of

Read More

Our Blog

Latest Tweets

Access to quality #cancer care in low-resource settings can be increased and expanded through collaborative & innov… https://t.co/Js6hEEUZ16
1 5
RT @FIP_org: In a post-pandemic scenario, it will be crucial to protect & further advance the progress that had been achieved globally in t…
6
Intellectual property enables pharma companies to collaborate and voluntarily share knowledge with trusted partners… https://t.co/v5efOaUODL
6 9
📢The 11th edition of the #ARC2022 is approaching fast! Don’t miss the chance to listen to a wide variety of speaker… https://t.co/Vpopmxydgj
1
A new #NAMPerspectives outlines priorities for action in ensuring adequate pandemic preparedness that could result… https://t.co/NqxK5wsJA7
1